MSR6 Modeling Survival of People with Cystic Fibrosis (PWCF) Aged ≥6 Years Heterozygous for the F508DEL Mutation with a Minimal Function Mutation (F/MF) in Brazil Treated with Elexacaftor/Tezacaftor/Ivacaftor and Ivacaftor (ELX/TEZ/IVA)

Saved in:
Bibliographic Details
Published in:Value in health 2022-07, Vol.25 (7), p.S518
Main Authors: Pedra, G, Daly, C, Pinto, LA, Lopez, A, Vega-Hernandez, G, Rubin, JL
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2022.04.1213